Pharmacologic (PPC) and ischemic preconditioning (IschPC) provide comparable protection against ischemia in the heart. However, the genomic phenotype may depend on the type of preconditioning. Isolated perfused rat hearts were used to evaluate transcriptional responses to PPC and IschPC in the presence (mediator/effector response) or absence (trigger response) of 40 min of test ischemia using oligonucleotide microarrays. IschPC was induced by 3 cycles of 5 min of ischemia, and PPC by 15 min of 2.1 vol-% isoflurane.
Introduction
Preconditioning is a most powerful means of attaining myocardial protection against prolonged ischemia (27) . It can be elicited by single or multiple brief episodes of sublethal ischemia (IschPC) or by pharmacological agents (PPC). This phenomenon called classic or early preconditioning establishes a transient protective cellular state in the myocardium by complex multiple fast-acting signaling steps lasting 2-3 hours.
Preconditioning further triggers a delayed cardiac protection, also called late preconditioning or "second window of protection", which occurs 12-24 hrs after the initial preconditioning stimulus and is effective for 3-4 days (25). This delayed protection relies on altered gene activity.
Volatile anesthetics emerged as a model class of agents eliciting PPC with low toxicity and high clinical applicability (51, 53). Even small doses of volatile anesthetics are capable of producing profound cardioprotection. PPC by volatile anesthetics and IschPC similarly augment postischemic functional recovery, decrease infarct size, elicit a "second window of protection" (41, 45), and, most importantly, were shown to occur in humans with coronary artery disease (20) . The signaling cascades of both types of preconditioning involve several G-protein coupled receptors, alterations in nitric oxide and free oxygen radical formation, and point to the key role of protein kinase C (47) as signal amplifier and to K ATP channels as the main end-effectors in preconditioning (52). Conversely, despite the same degree of structural and functional protection, differences with respect to key signaling steps were also reported (5, 47) . These include differential activation and translocation of protein kinase C isoforms to subcellular targets (47) as well as the role of other intracellular kinases (5) in triggering and mediating preconditioninginduced cardioprotection. The data presented herein provide additional new insights into the molecular similarities of the transcriptional responses between different types of preconditioning in the myocardium, and ultimately aid to conceptualize the molecular events surrounding the remarkable protection achieved by preconditioning. 
Materials and Methods

All experimental protocols used in this investigation
Langendorff Isolated Heart Preparation
Male Wistar rats (250 g) were heparinized (500 units i.p.) and 20 min later decapitated without prior anesthesia. The hearts were rapidly removed and perfused in a non-circulating Langendorff apparatus with Krebs-Henseleit buffer (in mmol/L, gassed with 95% O 2 /5% CO 2 and maintained at a pH of 7.4 and a temperature of 37°C. Perfusion pressure was set to 80 mmHg. A water-filled balloon was inserted into the left ventricle and inflated to set an end-diastolic pressure of 0-5 mmHg during the initial equilibration. Data were recorded as previously described in detail (5, 47) .
Perfusion Protocols and Hemodynamics
Hearts were allowed to equilibrate for 10 minutes and to beat spontaneously in all experiments ( Figure 1 
RNA Isolation and cDNA Synthesis
Left ventricular tissue was rapidly frozen in liquid nitrogen and stored at -80°C.
Hearts were powdered in liquid nitrogen and homogenized in TRIzol LS reagent (Invitrogen, Basel, Swizerland) and chloroform/isoamyl alcohol (Fluka, Buchs, Switzerland). The aqueous phase was mixed with isopropanol and precipitated over night at -20°C. The pellet was washed with isopropanol, dried at 37°C, and eluted in diethyl pyrocarbonate-treated H 2 O. In the presence of the T7-(T) 24 RNA polymerase promoter primer (Microsynth GmbH, Balgach, Switzerland), singlestrand cDNA synthesis from total RNA was performed using Superscript II (Invitrogen, Basel, Swizerland). Double-strand cDNA was synthesized with Superscript kit (Invitrogen, Basel, Swizerland). Biotin-labeled antisense cRNA was synthesized in vitro using a high-yield RNA transcript labeling kit (BioArray; Enzo, Farmingdale, NY USA).
Microarray Hybridization and Scanning
Affymetrix Rat Genome U34A array (Affymetrix, Santa Clara, CA USA) was used for gene expression profiling. Gene chip U34A contains a total of 8799 probe sets representing ~7000 known rat genes and 1000 expressed sequence tags (ESTs).
Five independent gene chips for each group were used resulting in a total of 30 chips analyzed. The biotin-labelled cRNA was fragmented in fragmentation buffer (200 mM Tris-acetate, 50 mM KOAc, 150 mM MgOAc, at pH 8.1) and hybridized to the oligonucleotides in hybridization solution containing 15 µg fragmented cRNA in MES buffer (0.1 M Mes, 1.0 M NaCl, 0.01 % Triton X-100, at pH 6.7) and herring sperm DNA. Chips were placed in a hybridization oven at 60 rpm and 45°C for 16 h.
Afterwards, arrays were first washed at 22°C with SSPE-T (0.9 M NaCl, 60 mM NaH 2 PO 4 , 6 mM EDTA, 0.005 % Triton X-100, at pH 7.6), and subsequently with 0.1 MES at 45°C for 30 min. The gene chips were then stained with a streptavidinphycoerythrin conjugate (Molecular Probes, Leiden, The Netherlands) and washed.
Additional staining with anti-streptavidin antibody and streptavidin-phycoerythrin conjugate was used to enhance the signals. Chips were scanned at a resolution of 3 µm using a confocal scanner (model 900154, Affymetrix, Santa Clara, CA USA).
From the 30 U34A chips analyzed, one chip of the IPC_TRI group did not satisfy the stringent quality criteria, and was therefore excluded from further analysis. For all other experimental groups, 5 chips, each resulting from an individual experiment,
were of high quality and entered the subsequent bioinformatics analysis. The data are available at the Gene Expression Omnibus (GEO) web site under the series number GSE1616 (http://www.ncbi.nlm.nih.gov/geo/).
Analysis of Gene Expression Data
A flowchart illustrating the individual steps of data analysis can be viewed in supplementary material ( Figure S1 ).
Step 1 Normalization and computation of expression values were performed using the Robust Multichip Average (RMA) method (19) Hierarchical clustering was performed using the coupled two-way clustering (CTWC) algorithm (2, 11, 12) . The concept and underlying philosophy of this algorithm is based on an analogy to the physics of inhomogeneous ferromagnets and has been previously described in detail (2) . The method identifies submatrices of the total expression matrix, whose clustering analysis reveals partitions of genes and samples into stable classes. The transcripts analyzed were rearranged as ordered by the clustering algorithm, so that transcripts with the most similar expression patterns, as measured by the Euclidean distance, were placed adjacent to each other. Gene and sample clusters were regarded as stable according to specified size and stability index. The following parameters were used to optimize the resolution of the clustering process: gene cluster size ≥15, sample cluster size ≥4, stability threshold of gene and sample clusters ∆T ≥6K with one dropout for samples and 3 dropouts for genes at a single increment in T. Expression data were preprocessed using an iterative scaling and merging algorithm described in detail elsewhere (14) .
Step (6, 8) ).
Validation of Selected Gene Expression Levels By Quantitative Real-Time
Reverse Transcription Polymerase Chain Reaction (RT-PCR)
As an independent method of measuring levels of gene expression, RT-PCR was performed for 13 selected genes to confirm microarray data. The primers are listed in Table 1 . For each amplification, 20 µl of cDNA were diluted in water (1:10) before using as template for the QuantiTect SybrGreen RT-PCR kit (Qiagen, Hilden, Germany). RT-PCR quantification and determination of expression levels were performed on ABI Prism 7700 Sequence Detector Real-Time PCR machine (PerkinElmer, Foster City, CA USA). Amplification reactions were conducted with an initial step at 90°C for 3 min followed by 20-35 cycles. All PCR reactions were performed in triplicates and α-tubulin and aminopeptidase were used as reference controls.
Predicted size of PCR products was confirmed by agarose gel electrophoresis. For all controlled genes, the direction (up-and downregulation) as well as the strength of regulation agreed with RT-PCR results.
Results
Physiologic changes in hearts subjected to PPC and IschPC
PPC with isoflurane at 1.5 MAC over 15 min or IschPC with 3 cycles of 5 minutes of ischemia before prolonged test ischemia of 40 minutes equally improved postischemic functional recovery when compared to nonpreconditioned hearts ( Table   2 ). In the triggering protocols, PPC (APC_TRI) transiently increased coronary flow, but decreased developed pressure, heart rate, and inotropy, while IschPC (IPC_TRI) resulted in transient complete functional loss followed by rapid recovery of contractility to baseline values, which was accompanied by a compensatory and transient increase in coronary flow.
Pre-and postischemic cardiac gene expression is markedly and distinctly modulated by PPC and IschPC
To characterize genomic response to PPC (APC_TRI, APC) and IschPC (IPC_TRI, 
IschPC but not PPC elicits a postischemic gene expression profile similar to unprotected ischemic myocardium
Clustering analysis including all treatment groups
CTWC was applied to the ANOVA-filtered RMA data for all 6 treatment groups
The main cluster G1 (2212 genes) broke into eight stable clusters as follows ( (CTL, n=5), S5 (CTL+APC, n=10), S6 (APC_TRI, n=5), and S7 (IPC_TRI, n=4).
Principal component analysis of sample clusters established a close genomic relationship between IPC and ISCH, while APC was close to CTL (nonischemic healthy myocardium) ( Figure 3B ).
Clustering analysis including only trigger responses to preconditioning
To eliminate interference from protocols with test ischemia (APC, IPC, ISCH), additional subgroup analysis including the trigger protocols only was performed (APC_TRI (n=5), IPC_TRI (n=4), CTL (n=5), n tot =14) ( Figure 5 ). From the main gene cluster G1 (1011 genes) three stable gene clusters emerged: G2 (59 genes, upregulated in APC_TRI and IPC_TRI including nitric oxide synthase 2 (NOS2), mitogen-activated kinase kinase 2 (MAPKK2), and many receptors and ESTs), G3
(24 genes, upregulated in APC_TRI and IPC_TRI including B-cell translocation gene 1, chemokine ligand 10, best5 protein), G4 (404 genes, downregulated in APC_TRI and IPC_TRI including early growth response 1, peroxiredoxin 6, cytochrome c, cytochrome P450, oligoadenylate synthetase, LINE, enzymes involved in glucose and fatty acid metabolism, cell adhesion molecules, and many hsps and ribosomal proteins). The main sample cluster S1 broke into 2 stable clusters as follows ( Figure   5A ): S2 (CTL, n=5), S3 (APC_TRI+IPC_TRI, n=10). Although principal component analysis for the samples displayed differences between APC_TRI and IPC_TRI, only one stable cluster (S3) was identified for both ( Figures 5A and 5B ).
Clustering analysis including mediator/effector responses to preconditioning
A similar subgroup analysis was performed using mediator/effector protocols only Using cluster analysis, we were able to demonstrate that similar but distinct pre-and postischemic gene expression patterns characterize PPC and IschPC in the heart. Importantly, IschPC but not PPC elicits a postischemic gene expression profile similar to unprotected ischemic myocardium.
Discussion
We have used high-density oligonucleotide microarrays to assess global changes in gene expression that result from preconditioning in the myocardium to gain insight into the underlying complex molecular mechanisms of this highly cardioprotective treatment strategy. The goal of this study was also to identify common mediators and patterns of protection between different types of preconditioning that can be subjected to further investigation for their therapeutic potential. To this end, isolated perfused rat hearts were exposed to brief ischemic cycles or to the pharmacological agent isoflurane in the presence or absence of test ischemia. Our survey revealed important molecular footprints that paradigmatically highlight the biological processes underlying cardiac protection. 
Clustering analysis
We used the coupled two-way clustering (CTWC) method (2, 12) to identify patterns of genes within the large database. CTWC is characterized by a high robustness against noise and a natural ability to identify stable clusters, providing insight that would have been impossible by simply looking at particular gene lists.
Unique expression patterns emerged within the transcriptional responses and placed the expression of many transcripts into a more holistic context. The clusters included families of transcripts known to have similar function suggesting that this method closely followed biological likeness. In this study, we were able to track a genomic similarity between unprotected myocardium and IschPC. Although test ischemia itself activated protective genes, this may merely reflect the transcriptional response of the highly stressed but yet surviving myocardial tissue. Irrespectively, the gene expression profile of unprotected myocardium was clearly coupled to poor functional recovery and cell death and therefore represents the characteristic postischemic profile of the unprotected state. Likewise, the gene expression pattern of untreated virgin myocardium should be regarded as archetypal for nonischemic healthy myocardium. Collectively, using a global gene discovery approach (CTWC clustering), our data support the concept that PPC may be less harmful to the myocardium and thus superior to IschPC as therapeutic strategy in cardiac protection. However, since many genes separated protected from unprotected myocardium, the molecular similarity between IschPC and unprotected myocardium may be regarded as relative rather than absolute, and its significance remains to be determined.
Comparison between IschPC and PPC
In the present study, the regulation of many transcripts previously reported to be involved in preconditioning was confirmed, but some transcripts showed opposite regulation. However, preconditioning is a highly dynamic complex network of intricate mechanisms undergoing multiphase regulation. Accordingly, different mechanisms have been reported to be responsible for the protection at different time points after preconditioning (49). Also, the genomic trigger responses as measured after 3 hours in this study, do not necessarily reflect the transcriptional changes involved in delayed protection. To date, few studies used microarrays to uncover the complex molecular mechanisms underlying preconditioning (30, 34-37, 54). Onody et al.
observed upregulation of chaperonin ε (TCP-1ε) and ribosomal proteins in preconditioned rat hearts after test ischemia and reperfusion (30). Simkhovich et al.
reported the activation of a protective genetic program predominantly including various heat shock proteins and transcription factors in rat hearts after brief ischemic episodes (37). Albeit not directly comparable, the results of the present study in principle confirm and extend these findings as well as the results of our previous microarray study, where we investigated the trigger responses of brief episodes of ischemia as compared to a prolonged isoflurane exposure (110 min), but did not investigate protocols with test ischemia and reperfusion (35). In the latter study, a differential regulation of Hsp27, Hsp70, and programmed cell death 8 was observed in response to brief ischemia as compared to isoflurane exposure. In another study, 
Chaperones
Hearts exposed to global prolonged ischemia overexpressed many heat shock proteins independent of whether preconditioning was applied or not. Hsp27 scavenges cytochrome c (3), inhibits activation of caspase 3 (26), and blocks Fasrelated apoptotic pathways (15) . Hsp70 together with Hsp40 prevents mitochondrial release of cytochrome c and inhibits caspase 9 activation via Apaf-1 (26).
Interestingly, Hsp10 was exclusively upregulated in IPC, while Hsp20 was exclusively upregulated in APC. Hsp10 acts in collaboration with Hsp60 opposing the proapoptotic Bax (15), and Hsp20 was recently found to inhibit β-agonist-induced cardiac apoptosis (9). In the trigger responses (APC_TRI, IPC_TRI), several chaperones including Hsp8, Hsp20, and crystallin αB were jointly downregulated.
Collectively, these observations provide evidence for a highly dynamic and distinct regulation of chaperones in both IschPC and PPC.
Inflammation
Surprisingly and in contrast to previous work (28), the inflammatory response was profoundly and consistently downregulated in all protocols receiving prolonged ischemia and 3 hours of reperfusion independent of whether preconditioning was applied or not. Mediators of inflammation are known to be important in ischemia/reperfusion-induced myocardial damage, and their inhibition was previously implicated in the protection underlying preconditioning. In contrast, upregulation of cytokines at the late phase of IschPC may represent a cytoprotective mechanism (54) . It is possible that in the Langendorff model, which is virtually devoid of blood components, the inflammatory response may be limited to a short and blunted burst of inflammatory mediators at the early reperfusion (17) . Alternatively, it could be speculated that the observed delayed postischemic anti-inflammatory status reflects a counterregulatory response and simply represents the intrinsic protective response of the viable myocardium unmasked in the absence of leukocytes, macrophages, and other extrinsic proinflammatory components.
Transcription factors
Early growth response-1 (Egr-1), an immediate-early gene zinc finger transcription 
Long interspersed nucleotide elements (LINEs)
We have also uncovered a retrotransposon transcriptional burst. LINEs are long interspersed repeated retrotransposable elements and found in almost all eukaryotes 
Study limitations
The following remarks should be added. RT-PCR may be more powerful to detect gene regulation. Also, changes in mRNA levels may be not always correlated with 
